Details for New Drug Application (NDA): 073364
✉ Email this page to a colleague
The generic ingredient in HALOPERIDOL is haloperidol decanoate. There are twenty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 073364
Tradename: | HALOPERIDOL |
Applicant: | Lannett Co Inc |
Ingredient: | haloperidol lactate |
Patents: | 0 |
Suppliers and Packaging for NDA: 073364
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HALOPERIDOL | haloperidol lactate | CONCENTRATE;ORAL | 073364 | ANDA | Major Pharmaceuticals | 0904-7112 | 0904-7112-70 | 100 CUP, UNIT-DOSE in 1 CASE (0904-7112-70) / 5 mL in 1 CUP, UNIT-DOSE (0904-7112-41) |
HALOPERIDOL | haloperidol lactate | CONCENTRATE;ORAL | 073364 | ANDA | Lannett Company, Inc. | 54838-501 | 54838-501-15 | 15 mL in 1 BOTTLE, DROPPER (54838-501-15) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CONCENTRATE;ORAL | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Sep 28, 1993 | TE: | AA | RLD: | No |
Complete Access Available with Subscription